Skip to content
Finance Investment, Medical Health Aged Care

BlinkLab (ASX:BB1) commences partnership with Turning Pointe Autism Foundation for clinical study in children with autism in the US

BlinkLab Limited (ASX:BB1) 2 mins read

Sydney, NSW – May 2, 2024 – BlinkLab Limited (ASX: BB1), an innovative digital healthcare company renowned for its smartphone-based AI diagnostic tools for autism, has proudly announced a new partnership with the Turning Pointe Autism Foundation, based in Naperville, Illinois, to initiate a clinical study focused on enhancing autism diagnostics in children.

This strategic collaboration will utilize BlinkLab's cutting-edge technology to conduct a study involving 200 children—100 previously diagnosed with autism and 100 without. This endeavor is aimed at refining AI and machine learning algorithms in preparation for a larger, FDA registration study scheduled for the latter half of 2024.

Henk-Jan Boele, CEO of BlinkLab commented: “Our partnership with Turning Pointe is more than just collaboration. It is a major step toward fulfilling our mission to make well-established neurobehavioral testing clinically accessible and efficient. Turning Pointe’s dedication to quality education and support aligns perfectly with our goal of leveraging cutting-edge technology to better understand and assist individuals with autism. We are very excited about the possibilities that this collaboration offers for the advancement of autism diagnosis and care.” 

Brian Leedman, Chairman of BlinkLab commented: “I am excited to see that our first substantive news following our listing a few weeks ago is a collaboration with this prestigious group in the field of autism research in children. I anticipate many more important announcements such as these as we get closer to the commencement of our FDA registration study later this year”. 

About the Study

The study will utilise BlinkLab’s innovative smartphone platform to conduct neurobehavioral testing, including a range of neurometric assessments. This method allows for the precise measurement of various responses and is designed to be non-invasive and child-friendly. The study has been approved by the institutional review board of Princeton University and will adhere to all pertinent guidelines and regulations.


About us:

BlinkLab, a company founded by neuroscientists at Princeton University, over the past several years has fully developed a smartphone based diagnostic platform for autism, ADHD, schizophrenia, and other neurodevelopmental conditions. BlinkLab’s most advanced product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as 18 months old. This marks a significant advancement, considering traditional diagnoses typically occur around five years of age, often missing the crucial early window for effective intervention. BlinkLab is led by an experienced management team and directors with a proven track record in building companies and vast knowledge in digital healthcare, computer vision, AI and machine learning. Our Scientific Advisory Board consists of leading experts in the field of autism and brain development allowing us to bridge the most advanced technological innovations with groundbreaking scientific research. 


Contact details:

Jane Morgan

jm@janemorganmanagement.com.au

Media

More from this category

  • Medical Health Aged Care
  • 23/05/2024
  • 11:26
Royal Australian College of GPs

“No patients should miss out”: GPs call for urgent action on payroll tax hit

The Royal Australia College of GPs (RACGP) is calling on all state and territory governments to save the future of general practice care so that no patients miss out. It comes ahead of the College’s annual Practice Owner’s National Conference in Cairns running 24 to 26 May. This year’s conference includes a presentation entitled Empowering Practices Through Payroll Tax: Reflecting, Positioning, and Advancing. Conducted by Senior Associate Ben Ryan and former RACGP Vice President and Queensland Chair, DrBruceWillett, the session focusses on the challenges posed by this payroll tax hit, the achievements of the College so far fighting for a…

  • Medical Health Aged Care
  • 23/05/2024
  • 11:17
Dementia Australia

On this weekend – Brisbane Memory Walk & Jog

The 2024 Brisbane Memory Walk & Jog is upon us, with the much-anticipated event taking place this weekend on Sunday 26 May at Rocks Riverside Park, Seventeen Mile Rocks. Starting at 7.30am, we welcome everyone in the Brisbane community to join fellow participants as they walk, jog or run to help raise money in support of people living with dementia. Special guests, Dementia Australia Ambassador Wally Lewis AM will be in attendance alongside this year’s MC Dementia Australia Ambassador Takaya Honda. Registrations for the Brisbane Memory Walk & Jog are still open and we would love to see as many…

  • Contains:
  • Medical Health Aged Care
  • 23/05/2024
  • 11:14
Dementia Australia

On this weekend – Perth Memory Walk & Jog

The 2024 Perth Memory Walk & Jog is upon us, with the much-anticipated event taking place this weekend on Sunday 26 May at Burswood Park, Burswood. Starting at 7.30am, we welcome everyone in the Perth community to join fellow participants as they walk, jog or run to help raise money in support of people living with dementia. Registrations for the Perth Memory Walk & Jog are still open and we would love to see as many people as possible participate to help raise funds and awareness for such an important cause. Walk or jog with us. We are in this…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.